The centre in Uppsala will use the pharmacokinetic data to calculate the dose of factor VIII (to be infused on alternate days) required to maintain a predicted factor VIII ≥1.5 IU/dL at all times, and inform the patient's centre of the dose to prescribe (this will be rounded up to the nearest full 250 IU vial).